Aniracetam is primarily used in research focused on cognitive enhancement, memory modulation, and neuroprotective mechanisms. It belongs to the racetam family of nootropics and has been widely studied for its unique effects on neurotransmitter activity, particularly in relation to learning, mood, and attention. Research involving Aniracetam spans multiple disciplines, including behavioral neuroscience, psychopharmacology, and neurobiology.

• Cognitive Enhancement Studies: Aniracetam is often evaluated for its ability to improve memory formation, retrieval, and overall learning capacity in both animal models and in vitro studies. It’s particularly noted for enhancing performance in short-term cognitive tasks.

• Neurotransmitter Modulation Research: Researchers study how Aniracetam influences neurotransmitters like acetylcholine and glutamate. It is believed to potentiate AMPA receptors, a subtype of glutamate receptors, which are critical for synaptic transmission and plasticity.

• Anxiolytic Mechanism Investigations: Unlike many racetams, Aniracetam shows potential anxiolytic (anti-anxiety) effects. Research explores how it modulates dopamine and serotonin receptors in the prefrontal cortex, impacting mood regulation.

• Neuroplasticity Exploration: Studies often include Aniracetam when investigating synaptic plasticity — the brain’s ability to reorganize and adapt — which is foundational for learning and recovery from injury.

• Age-Related Cognitive Decline Models: In rodent studies simulating age-related memory loss, Aniracetam has demonstrated potential in reversing or mitigating memory impairments, making it a subject of interest in Alzheimer’s-related research.

• Oxidative Stress and Neuroprotection: Some studies explore its potential in shielding neurons from oxidative damage, investigating how Aniracetam might protect against cellular degeneration and improve neural resilience.

Aniracetam’s legal status varies significantly by country and jurisdiction. While it’s not classified as a controlled substance in many regions, it is not approved as a dietary supplement or medication in most territories either. At RC Plug, we provide Aniracetam strictly for research purposes in compliance with international shipping and privacy protocols.

• United States (US): Aniracetam is unregulated and not scheduled by the DEA. It can be legally purchased for research purposes but is not FDA-approved for human consumption.

• European Union (EU): Legal status varies by country. For example, Germany requires a prescription, while other countries may allow importation for personal research use. Always check your local regulations.

• United Kingdom (UK): Aniracetam is considered an unlicensed medicine. It is not illegal to possess, but sale or promotion for human consumption is restricted.

• Canada and Australia: Importation can be heavily restricted. Customs agencies may seize products not clearly labeled for laboratory or research use.

• Research Use Only Clause: We clearly mark all our Aniracetam shipments as being for laboratory and research use only, which aligns with the legality of possession and usage in many scientific contexts.

• Customs Advisory: Customers are responsible for understanding and adhering to their local laws. RC Plug is not liable for seizures resulting from non-compliance with regional regulations.

Proper storage of Aniracetam is essential to preserve its chemical integrity, potency, and stability over time. Improper storage can lead to moisture absorption, degradation, and loss of efficacy, which may compromise experimental results.

• Cool, Dry Environment: Store Aniracetam in a dry place at room temperature (ideally 15–25°C or 59–77°F), away from heat sources, open windows, or direct sunlight.

• Airtight Containers: Always keep the compound sealed in its original airtight container or a high-quality laboratory-grade container to avoid exposure to air, which may lead to oxidation.

• Desiccants Recommended: Include silica gel or moisture-absorbing packs to minimize humidity inside the storage vessel, especially in humid climates.

• Avoid Light Exposure: Aniracetam is sensitive to light, particularly UV rays, which can degrade its molecular structure. Use opaque or amber glass containers for extended storage.

• Refrigeration Optional: While not mandatory, refrigeration may enhance shelf life, especially for long-term storage. Ensure the compound is kept dry and well-sealed if refrigerated.

• Away from Children and Pets: Even though it is intended for research only, always store Aniracetam in a secure place inaccessible to children, animals, or unauthorized personnel.

In research settings, Aniracetam is frequently combined with other compounds for experimental purposes. These combinations, often referred to as “stacks,” are intended to study synergistic effects on cognitive performance, neurotransmission, or neuroprotection. However, precise documentation and caution are necessary.

• Choline Sources: Aniracetam is often studied alongside choline supplements like Alpha-GPC or Citicoline to investigate how acetylcholine precursor availability influences memory, learning, and mental clarity.

• Other Racetams: Researchers may pair Aniracetam with compounds like Piracetam or Oxiracetam to compare efficacy, speed of action, and receptor interactions in multi-compound models.

• Nootropic Synergy: Some studies explore Aniracetam in combination with adaptogens, stimulants, or mood regulators to assess how it enhances or balances other neuroactive compounds.

• Controlled Environment Required: Mixing compounds requires a tightly controlled lab setup. Each compound’s identity, dosage, and interaction profile should be clearly documented before testing.

• Analytical Calibration: Researchers must ensure precise calibration of measurement tools and use validated dosing models when combining substances to avoid compounding errors.

• Toxicology Consideration: All combinations should be subject to toxicology screening, even if compounds are individually recognized as low-risk, to ensure safety in experimental contexts.

Understanding the half-life of Aniracetam is essential for designing research protocols that examine its duration of action, onset timing, and metabolic behavior. Its relatively short half-life contributes to its fast-acting nature and makes it suitable for short-term cognitive and behavioral experiments.

• Short Half-Life: Aniracetam’s half-life is approximately 1 to 2.5 hours, meaning it is quickly absorbed and metabolized, leading to a rapid onset and decline of effects.

• Fast-Acting Profile: Due to its fat-solubility, Aniracetam crosses the blood-brain barrier rapidly, making it ideal for acute studies involving cognitive performance or anxiety reduction.

• Requires Repeated Dosing for Prolonged Trials: Because of the short half-life, studies requiring extended exposure may involve multiple dosing intervals throughout the testing period.

• Metabolite Activity: Some of Aniracetam’s effects may persist longer than its half-life due to the active role of its metabolites, such as N-anisoyl-GABA.

• Impact on Research Timelines: Researchers must structure experiments within the window of maximum concentration to capture the compound’s full effect before clearance begins.

• Influence on Study Design: When used in comparative trials, its short half-life makes it ideal for examining differences in onset and peak performance among racetams.

Purity is a critical factor in chemical research, as even small contaminants can affect experimental outcomes and reproducibility. At RC Plug, we are committed to supplying Aniracetam that meets or exceeds stringent quality standards, verified through advanced laboratory testing.

• ≥99% Purity Level (HPLC Verified): Our Aniracetam undergoes high-performance liquid chromatography (HPLC) analysis to ensure a minimum of 99% purity. This level of precision helps maintain consistency across multiple research batches.

• Third-Party Laboratory Testing: Every batch is independently tested by accredited laboratories. These labs check for residual solvents, heavy metals, microbial presence, and other potential contaminants that could interfere with test results.

• Batch-Specific Documentation: We provide a Certificate of Analysis (COA) with every order upon request. Each COA includes a detailed breakdown of purity, lot number, analytical method, and testing date.

• Free from Solvents and Additives: Our Aniracetam is not diluted or cut with other substances. It is delivered as a pure, lab-grade powder, ready for immediate research use.

• Consistency Across Shipments: We source our Aniracetam from stable, regulated suppliers, ensuring uniformity in physical properties, solubility, and chemical structure across different batches.

• Proper Packaging for Purity Protection: Each unit is packaged in moisture-resistant, airtight containers to prevent degradation or contamination during storage and shipping.

Yes, Aniracetam has a well-established role in preclinical research, particularly in animal models exploring cognitive function, stress response, and neurodegenerative conditions. Its pharmacokinetics and behavioral effects have been widely observed in rodents and other small mammals.

• Rodent Learning Models: Aniracetam is often used in maze tests (such as the Morris water maze or radial arm maze) to study spatial learning, memory recall, and task acquisition in rats and mice.

• Age-Related Decline Studies: Researchers apply Aniracetam in studies involving aged animals to explore its potential to reverse or mitigate memory deficits, oxidative damage, and synaptic loss.

• Anxiolytic Testing: In elevated plus maze or open field tests, Aniracetam demonstrates potential anti-anxiety effects, making it useful for examining behavioral modulation under stress.

• Dose Adjustment by Species and Weight: Dosages are calibrated based on species and body mass (commonly between 10–100 mg/kg), and must follow ethical standards and approved experimental design.

• Biomarker Monitoring: Animal trials using Aniracetam often monitor neurotransmitter levels, such as acetylcholine and dopamine, alongside behavioral data to assess biochemical effects.

• Safety Profile in Animals: Studies report low toxicity and good tolerance in rodents at standard dosages, though detailed logs must be kept for each study to verify species-specific responses.

The solubility profile of Aniracetam is a key consideration for researchers preparing solutions for in vitro assays or in vivo delivery. Aniracetam is known to be fat-soluble and dissolves more efficiently in non-polar or semi-polar solvents.

• Poor Water Solubility: Aniracetam is practically insoluble in water, making aqueous solutions unsuitable for most research purposes.

• Ethanol Solubility: It dissolves well in ethanol at approximately 3–5 mg/mL. This solvent is commonly used in solution preparation for its rapid solubilization capability.

• DMSO Compatibility: Dimethyl sulfoxide (DMSO) is another effective solvent for Aniracetam. It offers higher solubility rates but should be used with caution in biological experiments due to potential cell permeability issues.

• PEG (Polyethylene Glycol): PEG solutions can be used when a more controlled release or extended dissolution profile is needed in specific experimental setups.

• Use of Sonication: Mild sonication can improve dissolution, especially in lab setups where heating is not desirable or could affect compound stability.

• Avoid Strong Acids or Bases: These may degrade Aniracetam’s molecular structure. Neutral or mildly polar solvents are preferred for preserving compound integrity.

Like all research compounds, Aniracetam is susceptible to degradation if not stored and handled properly. Maintaining its chemical stability ensures accurate, reproducible results in long-term studies or repeated trials.

• Sensitive to Moisture and Humidity: Aniracetam readily absorbs moisture from the air, which can lead to hydrolysis and reduced efficacy. Always keep it in sealed containers with desiccants.

• Heat Exposure Risks: High temperatures can accelerate decomposition. Avoid storing it near heat sources, direct sunlight, or in vehicles.

• Light-Induced Degradation: UV light can break down the molecular bonds of Aniracetam, especially if left exposed in clear containers. Always use amber or opaque storage containers.

• Shelf Life: Properly stored, Aniracetam remains stable for up to 2 years. However, periodic inspections are recommended, especially if the compound has been opened or repackaged.

• Visual Indicators: If the powder changes color (from white/off-white to yellow or brown) or develops an unusual odor, it may be degraded and unsuitable for continued research use.

• Storage Conditions: Ideal storage conditions include 15–25°C with humidity below 60%. Refrigeration is optional but can extend shelf life if the container is moisture-resistant.

Though Aniracetam and Piracetam belong to the same racetam family, their pharmacological profiles differ significantly in solubility, potency, and mechanisms of action. Understanding these differences is important for comparative research.

• Solubility Profile: Aniracetam is fat-soluble (lipophilic), allowing it to cross the blood-brain barrier more quickly than Piracetam, which is water-soluble and absorbed more slowly.

• Potency and Dosage: Aniracetam is considered to be more potent than Piracetam, requiring lower doses to achieve similar cognitive outcomes in many animal studies.

• Onset and Duration: Aniracetam has a faster onset but a shorter half-life (1–2.5 hours) compared to Piracetam’s longer half-life (4–5 hours), making it more suitable for short-term effect trials.

• Anxiolytic Potential: Unlike Piracetam, Aniracetam has shown potential anxiolytic properties in research, possibly due to its influence on serotonin and dopamine receptors in the limbic system.

• Receptor Modulation: Aniracetam has a stronger effect on AMPA receptors (glutamate subtype), whereas Piracetam’s primary action appears to enhance membrane fluidity and modulate cholinergic transmission more broadly.

• Research Focus Differences: Piracetam is often used in long-term studies involving neuroprotection and general cognitive enhancement, while Aniracetam is typically chosen for short-term memory and mood-focused research.

Yes, Aniracetam is actively studied for its impact on several major neurotransmitter systems, particularly those involved in cognition, mood regulation, and synaptic plasticity. Its mechanism of action is multifaceted, which is why it’s of high interest in neuropharmacological research.

• AMPA Receptor Modulation: Aniracetam is a positive allosteric modulator of AMPA receptors, a subtype of glutamate receptors. This action enhances excitatory neurotransmission and is believed to play a central role in its cognitive-enhancing properties.

• Cholinergic System Support: Studies show Aniracetam increases acetylcholine release and enhances muscarinic receptor function, which can lead to improved memory encoding and attention in animal models.

• Dopaminergic Effects: Evidence suggests Aniracetam influences dopamine levels, particularly in the prefrontal cortex. This activity may underlie its reported benefits for motivation and mood stability.

• Serotonin Pathway Interaction: By modulating serotonin receptors, especially 5-HT2A and 5-HT1A, Aniracetam may exert anxiolytic effects and influence emotional processing in stress-based models.

• Indirect BDNF Influence: While not a direct BDNF (brain-derived neurotrophic factor) enhancer, Aniracetam’s impact on glutamatergic transmission may indirectly promote BDNF expression, supporting neuroplasticity and learning.

• Reduced Neural Desensitization: By modifying receptor sensitivity and excitatory balance, Aniracetam may help reduce the desensitization effects that impair long-term synaptic efficiency in aged or impaired brains.

The optimal research dosage of Aniracetam depends heavily on the species used, route of administration, and experimental objectives. While human-based dosing is not applicable here, preclinical trials provide valuable reference points for in vivo and in vitro applications.

• Rodent Dosage Guidelines: Most studies in rats and mice utilize doses ranging from 10 to 100 mg/kg, often administered orally or via injection. Dose should always be calculated according to weight and species.

• Intraperitoneal vs. Oral: Intraperitoneal (i.p.) administration offers faster absorption but may differ from oral pharmacokinetics. Choose based on study design and desired plasma concentration curve.

• In Vitro Application: For cell line or tissue studies, microgram-scale dilutions in suitable solvents like DMSO or ethanol are used to examine molecular interactions at receptor or channel levels.

• Dosing Frequency: Due to its short half-life, multiple administrations may be required throughout the day in long-term studies to maintain a consistent concentration in systemic circulation.

• Documentation is Essential: All administered doses, intervals, and response observations should be recorded precisely for replication and peer validation.

• Species-Specific Adjustments: Always consider metabolic rate and brain-to-body ratio differences across species to refine experimental accuracy.

Yes, we provide full documentation with every purchase upon request. At RC Plug, we believe transparency is essential for credible scientific research, and we are committed to providing the necessary data to support your experimental integrity.

• Certificate of Analysis (COA): Each batch of Aniracetam comes with a COA detailing purity levels, chemical identifiers, testing methods (such as HPLC), and batch numbers to ensure traceability.

• Material Safety Data Sheet (MSDS): Our MSDS includes detailed information about chemical properties, storage instructions, handling precautions, hazard identification, and first aid measures for lab environments.

• Third-Party Verified Results: All analytical results listed in the COA are conducted by independent laboratories, ensuring unbiased verification of product quality.

• Compliance with Research Standards: Both COA and MSDS are formatted in accordance with globally accepted laboratory and safety documentation practices (e.g., GHS and REACH guidelines).

• Digital or Physical Copies: You may request PDF versions electronically or physical printouts included in your package.

• Request Process: After placing your order, simply email or message our support team with your order ID to receive the full documentation set.

Aniracetam is not classified as a traditional psychoactive substance, but its effects on cognition, emotion, and behavior have led some researchers to explore its psychoactive potential in regulated lab studies. Its influence is subtle and distinct from that of stimulants or hallucinogens.

• Non-Stimulant Cognitive Effects: Aniracetam does not produce euphoria or hyperactivity. Its psychoactivity lies in its cognitive sharpening and mood-stabilizing properties observed in lab animals.

• Anxiolytic Potential: Research suggests Aniracetam may reduce anxiety in stress-sensitive models by modulating serotonin and dopamine pathways, affecting mood regulation centers in the brain.

• No Recreational Profile: Aniracetam lacks addictive potential or hedonic reward mechanisms and does not activate the mesolimbic “reward pathway” like traditional psychoactive drugs.

• Modulation Without Intoxication: Subjects in trials often show improved focus, learning, and reduced social anxiety without exhibiting intoxicated behavior or sedation.

• Prefrontal Cortex Influence: Its impact on higher-level brain functions like decision-making and perception make it relevant in psychopharmacology, even if it is not conventionally psychoactive.

Aniracetam belongs to the racetam class of synthetic compounds. Racetams are a family of nootropics known for their effects on memory, learning, and cognition. They share a common pyrrolidone nucleus but vary widely in potency, receptor binding, and pharmacological effects.

• Core Structure: All racetams feature a 2-pyrrolidone base structure. Aniracetam differs by including an anisoyl group that enhances fat solubility and brain penetration.

• Synthetic Origins: Aniracetam was first developed in the 1970s by Hoffmann-La Roche as a more potent and faster-acting derivative of Piracetam.

• Fat-Soluble (Lipophilic): Unlike many racetams, Aniracetam is lipophilic. This makes it more bioavailable in lipid-rich brain tissues and quicker in action.

• Cognition-Focused Class: The racetam class is almost exclusively studied for their cognitive benefits, including memory enhancement, attention improvement, and neuroprotection.

• Not a Natural Compound: Aniracetam does not occur naturally and is not found in plants or foods. It is entirely synthetic and intended for controlled research use only.

Aniracetam undergoes rapid metabolism once administered, especially when used in vivo for research. The active and inactive metabolites resulting from this process play significant roles in its pharmacodynamics and influence the outcomes of neuropharmacological experiments.

• N-anisoyl-GABA: This is the primary active metabolite of Aniracetam. It is believed to contribute to the anxiolytic effects observed in various behavioral models by interacting with GABAergic and glutamatergic systems.

• 2-Pyrrolidinone: A secondary metabolite formed after Aniracetam breaks down. While not active in the same cognitive-enhancing sense, its presence is an important indicator of metabolic completeness in pharmacokinetic studies.

• p-Anisic Acid: Also produced during Aniracetam metabolism, this compound is considered inactive in cognitive or behavioral terms but is relevant in metabolite profiling and elimination studies.

• Rapid Metabolic Clearance: Due to the compound’s short half-life, these metabolites appear in plasma shortly after administration, contributing to Aniracetam’s fast onset and brief duration of action.

• Implications for Research Design: Studies focusing on bioavailability or receptor specificity often isolate these metabolites to understand their unique roles or rule out confounding variables.

• Metabolic Pathway Consistency: The metabolism of Aniracetam is consistent across mammalian species, making it a useful candidate for cross-species comparison in preclinical trials.